First-in-human study of a novel Upar-targeted imaging agent (FGO01) for visualization of malignant glioma during surgery
Main Authors: | J. Skjøth-Rasmussen, A. Azam, K. Juhl, S. Ginsborg, M. Kryspin Sørensen, C. Sølling, C.C. Larsen, D. Scheie, A. Kjaer |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-01-01
|
Series: | Brain and Spine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772529422006403 |
Similar Items
-
Peptide-Based Optical uPAR Imaging for Surgery: In Vivo Testing of ICG-Glu-Glu-AE105.
by: Karina Juhl, et al.
Published: (2016-01-01) -
Hyperlactatemia associated with elective tumor craniotomy: Protocol for an observational study of pathophysiology and clinical implications.
by: Alexandra Vassilieva, et al.
Published: (2022-01-01) -
SMARTPHONE LEVEL INDOOR/OUTDOOR UBIQUITOUS PEDESTRIAN POSITIONING 3DMA GNSS/VINS INTEGRATION USING FGO
by: H.-Y. Ho, et al.
Published: (2023-05-01) -
Targeting uPAR by CRISPR/Cas9 System Attenuates Cancer Malignancy and Multidrug Resistance
by: Kun Wang, et al.
Published: (2019-02-01) -
Data on the regulation of moesin and merlin by the urokinase receptor (uPAR): Model explaining distal activation of integrins by uPAR
by: Bernard Degryse, et al.
Published: (2017-12-01)